Livongo Health, Inc. Increase (Decrease) in Accounts Receivable
Livongo Health, Inc. reported Increase (Decrease) in Accounts Receivable of $20.01 million for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2020-08-10
- Livongo Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2020-06-30 was $8.20M, a 43.33% increase year-over-year.
- Livongo Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2020-03-31 was $11.81M, a 0.92% decline year-over-year.
- Livongo Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2019-12-31 was $328.00K, a 80.42% decline year-over-year.
- Livongo Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2019-09-30 was $5.80M, a 47.76% increase year-over-year.
- Livongo Health, Inc. increase (decrease) in accounts receivable for fiscal 2019 was $23.77M, a 159.09% increase from fiscal 2018.
- Livongo Health, Inc. increase (decrease) in accounts receivable for fiscal 2018 was $9.17M, a 70.17% increase from fiscal 2017.
- Livongo Health, Inc. increase (decrease) in accounts receivable for fiscal 2017 was $5.39M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2020-06-30 | $8.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $20.01M 10-Q · filed 2020-08-10 | $20.33M derived: sum of 3 quarters · filed 2020-08-10 | $26.14M derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | $11.81M 10-Q · filed 2020-05-07 | $12.13M derived: sum of 2 quarters · filed 2020-05-07 | $17.94M derived: sum of 3 quarters · filed 2020-05-07 | $23.66M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-12-31 | $328.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | $6.13M derived: sum of 2 quarters · filed 2020-03-24 | $11.85M derived: sum of 3 quarters · filed 2020-08-10 | $23.77M 10-K · filed 2020-03-24 |
| 2019-09-30 | $5.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $11.53M derived: sum of 2 quarters · filed 2020-08-10 | $23.44M 10-Q · filed 2019-11-08 | $25.12M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-06-30 | $5.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $17.64M 10-Q · filed 2020-08-10 | $19.31M derived: sum of 3 quarters · filed 2020-08-10 | $23.24M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $11.92M 10-Q · filed 2020-05-07 | $13.59M derived: sum of 2 quarters · filed 2020-05-07 | $17.52M derived: sum of 3 quarters · filed 2020-05-07 | |
| 2018-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | $5.60M derived: sum of 2 quarters · filed 2020-03-24 | $9.17M 10-K · filed 2020-03-24 | |
| 2018-09-30 | $3.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $7.50M 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $3.57M 10-Q · filed 2019-09-05 | |||
| 2017-12-31 | $5.39M 10-K · filed 2020-03-24 |